Feature | Heart Failure | February 16, 2022 | By Melinda Taschetta-Millane

Pig Heart Transplant Patient Continues to Thrive

Five weeks post-transplant surgery, David Bennett is doing well and had plans to watch the Super Bowl LVI, something he never dreamed would be possible

In January, The University of Maryland School of Medicine (UMSOM) and the University of Maryland Medical Center (UMMC) successfully executed a groundbreaking porcine heart transplant procedure in a human. This was the first successful transplant of a genetically modified pig’s heart into a human patient.

Porcine heart transplant patient David Bennett.


In January, The University of Maryland School of Medicine (UMSOM) and the University of Maryland Medical Center (UMMC) successfully executed a groundbreaking porcine heart transplant procedure in a human. This was the first successful transplant of a genetically modified pig’s heart into a human patient.

porcine heart transplant

Bartley P. Griffith, M.D., surgically transplants the pig heart into the patient, David Bennett. All photos from the University of Maryland Medical Center.

 

The heart transplant patient, a 57-year-old Maryland resident David Bennett, has been carefully monitored since the procedure to determine whether the transplant provides lifesaving benefits. He had advanced heart failure and had been deemed ineligible for a conventional heart transplant at UMMC as well as at several other leading transplant centers that reviewed his medical records. He was on ECMO for life support and was not expected to leave the hospital alive. 

“It was either die or do this transplant. I want to live. I know it’s a shot in the dark, but it’s my last choice,” Bennett said a day before the surgery was conducted. He had been hospitalized and bedridden for the past few months. “I look forward to getting out of bed after I recover.”

Five weeks later, UMMC issued an update, stating the Bennett is doing well and had plans to watch the Super Bowl LVI, something he never dreamed would be possible.

David Bennett

Bennett and two of his medical team doctors who saved his life.

 

“It's been more than a month since David Bennett's historic lifesaving xenotransplant surgery at the University of Maryland. In a recent video episode of Maryland Medicine Front Line News, doctors provide an update on his medical condition, and the performance of his transplanted pig heart. While his recuperation has been slow, Bennett is looking forward to watching the Super Bowl and eventually going home to see his dog Lucky,” UMMC said in a released video statement. The video discusses the research behind how the immune system regulates itself in the area of transplantation. 

 

 

The transplanted pig heart continues to perform beyond expectations. “His heart function looks great, his blood pressure is very good, in fact he’s on medicine to reduce his blood pressure,” said Bartley P. Griffith, M.D., Thomas E. and Alice Marie Hales, Distinguished Professor in Transplant Surgery at the University of Maryland School of Medicine, in the video. “That’s how good it is right now.”

Muhammad M. Mohiuddin, MBBS, Professor of Surgery and Director, Cardiac Xenotransplantation Program at the University of Maryland School of Medicine, agreed that Bennett’s heart is doing great. “We have several cardiologists trying to find any fault in it, but they have not been able to do it” he said. “The heart is contracting vigorously as it should, it has shown no signs of rejection, we are introducing new parameters to measure its function, and all the parameters are coming back as if his heart is as good as new.”

Mohiuddin describes Bennett as being very motivated. “Every time you talk to him, he has a desire to live.” Doctors will continue to monitor his condition closely, and adjust his immunosuppressive therapy as needed.

VIDEO: Details on the First Pig Heart Transplant Surgery in a Human

Read more on this heart transplant case: www.medschool.umaryland.edu/news/2022/University-of-Maryland-School-of-Medicine-Faculty-Scientists-and-Clinicians-Perform-Historic-First-Successful-Transplant-of-Porcine-Heart-into-Adult-Human-with-End-Stage-Heart-Disease.html

Related Heart Transplant News:

Unexpected Electrical Changes Seen in First Successful Transplant of Genetically-Modified Pig Heart

First Human Receives a Pig Heart Transplant

Transplanting Pig Hearts Into Humans One Step Closer

FDA OKs Use New Version of Carmat Artificial Heart in U.S. Early Feasibility Study

Carmat Artificial Heart Shows Promising Automatic Regulation of Blood Flow

Heart in a Box Technology Expands Heart Transplant Window

Abbott’s In-Development Fully Implantable Heart Pump System Earns FDA’s Breakthrough Device Designation

FDA Clears SynCardia 50cc Temporary Total Artificial Heart as Bridge to Transplant

Stephanie’s Heart: The Story of Baby Fae

Hearts from donors who used illicit drugs or overdosed safe for transplant, cuts wait time

National Trends in Heart Donor Utilization Rates: Are We Efficiently Transplanting More Hearts?

Heart transplants from donors with hepatitis C may be safe and could help decrease organ shortage

Find more cardiac surgery technology content

Find more heart failure technology content


Related Content

News | Heart Failure

May 22, 2024 — New research from The Cooper Institute and partners at University of Texas (UT) Southwestern Medical ...

Home May 22, 2024
Home
News | Heart Failure

April 30, 2024 — A multicenter study led by Vanderbilt University Medical Center (VUMC) and Lipscomb University College ...

Home April 30, 2024
Home
News | Heart Failure

April 16, 2024 — Each year more than 500,000 Americans undergo percutaneous coronary intervention, or PCI, a minimally ...

Home April 16, 2024
Home
News | Heart Failure

April 12, 2024 — University of Virginia School of Medicine researchers have discovered a gene on the Y chromosome that ...

Home April 12, 2024
Home
News | Heart Failure

April 2, 2024 — People who use e-cigarettes are significantly more likely to develop heart failure compared with those ...

Home April 02, 2024
Home
News | Heart Failure

March 29, 2024 — V-Wave announced it will present late-breaking data from its RELIEVE-HF pivotal trial at the American ...

Home March 29, 2024
Home
News | Heart Failure

March 25, 2024 — A team of engineers led by the University of Massachusetts Amherst and including colleagues from the ...

Home March 25, 2024
Home
News | Heart Failure

March 15, 2024 — BioCardia, Inc. , a biotechnology company focused on advancing late-stage cell therapy interventions ...

Home March 15, 2024
Home
News | Heart Failure

March 15, 2024 — BioCardia, Inc., a biotechnology company focused on advancing late-stage cell therapy interventions for ...

Home March 15, 2024
Home
News | Heart Failure

March 13, 2024 — BioCardia, Inc., a developer of cellular and cell-derived therapeutics for the treatment of ...

Home March 13, 2024
Home
Subscribe Now